Latest Breaking News On - Fate therapeutics inc - Page 1 : vimarsana.com

Fate Therapeutics (NASDAQ:FATE) versus Protara Therapeutics (NASDAQ:TARA) Financial Comparison

Fate Therapeutics (NASDAQ:FATE – Get Free Report) and Protara Therapeutics (NASDAQ:TARA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk. Analyst Ratings This is a summary of […]

Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Sold by Bruce & Co. Inc.

Bruce & Co. Inc. lowered its stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the period. Bruce & […]

Bruce & Co. Inc. Sells 57,000 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE)

Bruce & Co. Inc. trimmed its stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 28.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 143,000 shares of the biopharmaceutical company’s stock after selling 57,000 shares during the quarter. Bruce & […]

Sana Biotechnology (NASDAQ:SANA) and Fate Therapeutics (NASDAQ:FATE) Critical Comparison

Sana Biotechnology (NASDAQ:SANA – Get Free Report) and Fate Therapeutics (NASDAQ:FATE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Volatility & Risk Sana Biotechnology has a […]

Brokerages Set Fate Therapeutics, Inc. (NASDAQ:FATE) Price Target at $6.58

Certain Pre-Funded Warrants of Fate Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024.

Certain Pre-Funded Warrants of Fate Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024. These Pre-Funded Warrants will be under lockup for 61 days starting from 19-MAR-2024 to...

Fate Therapeutics, Inc. (NASDAQ:FATE) Short Interest Up 17.0% in April

Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 22,140,000 shares, a growth of 17.0% from the April 15th total of 18,920,000 shares. Based on an average daily volume of 2,620,000 shares, the days-to-cover ratio […]

StockNews.com Lowers Fate Therapeutics (NASDAQ:FATE) to Sell

BMO Capital Markets Trims Fate Therapeutics (NASDAQ:FATE) Target Price to $6.00

Canaccord Genuity Group Lowers Fate Therapeutics (NASDAQ:FATE) Price Target to $9.00